Genes in panel

Likely inborn error of metabolism - targeted testing not possible

Gene: NUS1

Amber List (moderate evidence)

NUS1 (NUS1 dehydrodolichyl diphosphate synthase subunit)
EnsemblGeneIds (GRCh38): ENSG00000153989
EnsemblGeneIds (GRCh37): ENSG00000153989
OMIM: 610463, Gene2Phenotype
NUS1 is in 8 panels

3 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

Green List (high evidence)

Comment on list classification: As there is sufficient evidence available for the association of monoallelic NUS1 variants with intellectual disability and epilepsy, this gene can be promoted to green rating in the next GMS review.
Created: 5 Jan 2024, 7:43 p.m. | Last Modified: 5 Jan 2024, 7:43 p.m.
Panel Version: 4.95
Comment on mode of inheritance: As reviewed by Dmitrijs Rots, there are more than three unrelated cases and functional evidence available in support of the association of monoallelic NUS1 variants with intellectual disability and epilepsy. This autosomal dominant disorder has been recorded in both OMIM (MIM #617831) and Gene2Phenotype (with 'strong' rating in the DD panel).

However, there is only one family and supporting functional evidence available for the association of biallelic variants with congenital disorder of glycosylation. This phenotype has already been recorded in OMIM (MIM #617082), but not in Gene2Phenotype.

Hence, the MOI should be updated from 'BIALLELIC, autosomal or pseudoautosomal' to 'MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted'.
Created: 5 Jan 2024, 7:40 p.m. | Last Modified: 5 Jan 2024, 7:40 p.m.
Panel Version: 4.94

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Intellectual developmental disorder, autosomal dominant 55, with seizures, OMIM:617831; ?Congenital disorder of glycosylation, type 1aa, OMIM:617082

Dmitrijs Rots (Children's Clinical University Hospital)

Green List (high evidence)

Multiple patients (see below) with de novo or heterozygous variants reported. The phenotype include ID, seizures and/or movement disorder (including tremor, ataxia, dystonia). Functional analysis of patients fibroblasts shows"de novo NUS1 variants reduce NgBR and Niemann–Pick type C2 (NPC2) protein amount, impair dolichol biosynthesis, and cause lysosomal cholesterol accumulation." (Yu et al,m 2021). Movement abnormalities and similar metabolic dysfunction in zebrafish model.

3 patients reported in: PMID: 33731878
One patient reported in: PMID: 32334381
One family reported in: PMID: 32485575
Two cases reported in: PMID: 31656175

Additionally, two cases from one family with homozygous missense variant is reported:PMID: 25066056
Metabolic defect include:"fibroblasts isolated from patients exhibit reduced dolichol profiles and enhanced accumulation of free cholesterol identically to fibroblasts from mice lacking NgBR", which seems to be in line with effect of dominant variants described above.
Created: 27 Jun 2021, 2:44 p.m. | Last Modified: 27 Jun 2021, 2:44 p.m.
Panel Version: 2.143

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
intellectual disability; seizures; ataxia; tremor; dystonia

Publications

Eleanor Williams (Genomics England Curator)

I don't know

Comment on list classification: Promoting from red to amber on advice from Genomics England clinical team. 1 case plus some functional data.
Created: 12 Jan 2021, 11:15 p.m. | Last Modified: 12 Jan 2021, 11:15 p.m.
Panel Version: 2.44
Provisionally associated with ?Congenital disorder of glycosylation, type 1aa #617082 (AR) in OMIM based on family reported in Park et al 2014 (PMID: 25066056). They describe a family of Roma origin in which 2 out of 4 siblings presented with congenital scoliosis, severe neurological impairment, refractory epilepsy, hearing deficit and visual impairment with discrete bilateral macular lesions. A homozgyous missense mutation, R290H, was found in NUS1 (called NGBR in the paper) by exome sequencing. It segregated with the disease in the family. Patient fibroblasts showed reduced dolichol profiles and enhanced accumulation of free cholesterol as do fibroblasts from mice lacking NgBR.
Created: 12 Jan 2021, 11:11 p.m. | Last Modified: 12 Jan 2021, 11:11 p.m.
Panel Version: 2.41

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
?Congenital disorder of glycosylation, type 1aa OMIM:617082; congenital disorder of glycosylation, type IAA MONDO:0014904

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
Phenotypes
  • Intellectual developmental disorder, autosomal dominant 55, with seizures, OMIM:617831
  • ?Congenital disorder of glycosylation, type 1aa, OMIM:617082
Tags
Q4_23_promote_green
OMIM
610463
Clinvar variants
Variants in NUS1
Penetrance
None
Publications
Panels with this gene

History Filter Activity

5 Jan 2024, Gel status: 2

Entity classified by Genomics England curator

Achchuthan Shanmugasundram (Genomics England Curator)

Gene: nus1 has been classified as Amber List (Moderate Evidence).

5 Jan 2024, Gel status: 2

Set mode of inheritance

Achchuthan Shanmugasundram (Genomics England Curator)

Mode of inheritance for gene: NUS1 was changed from BIALLELIC, autosomal or pseudoautosomal to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

5 Jan 2024, Gel status: 2

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: NUS1 were set to 25066056; 31656175; 32334381; 32485575; 33731878

5 Jan 2024, Gel status: 2

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: NUS1 were set to 25066056

5 Jan 2024, Gel status: 2

Set Phenotypes

Achchuthan Shanmugasundram (Genomics England Curator)

Phenotypes for gene: NUS1 were changed from ?Congenital disorder of glycosylation, type 1aa OMIM:617082; congenital disorder of glycosylation, type IAA MONDO:0014904 to Intellectual developmental disorder, autosomal dominant 55, with seizures, OMIM:617831; ?Congenital disorder of glycosylation, type 1aa, OMIM:617082

5 Jan 2024, Gel status: 2

Added Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q4_23_promote_green tag was added to gene: NUS1.

12 Jan 2021, Gel status: 2

Entity classified by Genomics England curator

Eleanor Williams (Genomics England Curator)

Gene: nus1 has been classified as Amber List (Moderate Evidence).

12 Jan 2021, Gel status: 1

Set publications

Eleanor Williams (Genomics England Curator)

Publications for gene: NUS1 were set to 25066056

12 Jan 2021, Gel status: 1

Set Phenotypes

Eleanor Williams (Genomics England Curator)

Phenotypes for gene: NUS1 were changed from ?Congenital disorder of glycosylation, type 1aa 617082 to ?Congenital disorder of glycosylation, type 1aa OMIM:617082; congenital disorder of glycosylation, type IAA MONDO:0014904

12 Jan 2021, Gel status: 1

Set publications

Eleanor Williams (Genomics England Curator)

Publications for gene: NUS1 were set to

8 Jan 2019, Gel status: 1

Panel promoted to version 1.0

Ellen McDonagh (Genomics England Curator)

Sarah Leigh: Associated with phenotype in O

16 Dec 2018, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Ellen McDonagh (Genomics England Curator)

gene: NUS1 was added gene: NUS1 was added to Inborn errors of metabolism. Sources: Expert Review Red Mode of inheritance for gene: NUS1 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: NUS1 were set to ?Congenital disorder of glycosylation, type 1aa 617082